168 related articles for article (PubMed ID: 15384699)
1. [Recent progress in chemotherapy for hepatocellular carcinoma].
Sakon M; Nagano H; Monden M
Nihon Naika Gakkai Zasshi; 2004 Aug; 93(8):1660-5. PubMed ID: 15384699
[No Abstract] [Full Text] [Related]
2. Durable clinical and pathologic response of hepatocellular carcinoma to systemic and hepatic arterial administration of platinol, recombinant interferon alpha 2B, doxorubicin, and 5-fluorouracil: a communication.
Patt YZ; Hoque A; Roh M; Ellis L; Lozano R; Carrasco CH; Charnsangavej C; Cleary K
Am J Clin Oncol; 1999 Apr; 22(2):209-13. PubMed ID: 10199464
[TBL] [Abstract][Full Text] [Related]
3. Factors predicting response and survival in 149 patients with unresectable hepatocellular carcinoma treated by combination cisplatin, interferon-alpha, doxorubicin and 5-fluorouracil chemotherapy.
Akçali Z; Akin E; Ozyilkan O
Cancer; 2002 Nov; 95(9):2038-9; author reply 2039. PubMed ID: 12404300
[No Abstract] [Full Text] [Related]
4. Continuous infusional 5-fluorouracil chemotherapy.
Olthoff KM; Rosove MH; Shackleton CR; Imagawa DK; Farmer DG; Northcross P; Pakrasi AL; Martin P; Goldstein LI; Shaked A; Busuttil RW
Ann Surg; 1996 Nov; 224(5):686. PubMed ID: 8916883
[No Abstract] [Full Text] [Related]
5. [The chemotherapy for hepatocellular carcinoma].
Nagano H; Sakon M; Monden M
Gan To Kagaku Ryoho; 2003 Nov; 30(12):1895-900. PubMed ID: 14650956
[TBL] [Abstract][Full Text] [Related]
6. [Hepatic arterial infusion chemotherapy (HAIC)--hepatocellular carcinoma].
Osuga K; Murakami T; Nakata S; Tomoda K; Nagano H; Monden M; Nakamura H
Gan To Kagaku Ryoho; 2004 Dec; 31(13):2114-7. PubMed ID: 15628754
[TBL] [Abstract][Full Text] [Related]
7. [Intermittent intra-arterial chemotherapy using subcutaneously implanted reservoir for hepatocellular carcinoma and liver metastasis of colorectal carcinoma].
Nakazaki H; Kuramoto S; Watanabe M; Maeda T; Hanawa S; Hasebe Y; Suzuki Y; Yanagita K; Yoshio T
Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1501-3. PubMed ID: 1326917
[TBL] [Abstract][Full Text] [Related]
8. [The progress of hepatic arterial infusion chemotherapy for hepatocellular carcinoma].
Noda T; Nagano H; Wada H; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Dono K; Ohsuga K; Kim T; Tomoda K; Nakamura H; Monden M
Gan To Kagaku Ryoho; 2006 Sep; 33(9):1221-5. PubMed ID: 16969014
[TBL] [Abstract][Full Text] [Related]
9. [Postoperative adjuvant intraarterial chemotherapy of combined cisplatin and 5-FU for advanced hepatocellular carcinoma].
Kamiyama T; Nakagawa T; Nakanishi K; Kurauchi N; Kamachi H; Matsushita M; Todo S
Gan To Kagaku Ryoho; 2003 Oct; 30(11):1618-20. PubMed ID: 14619478
[TBL] [Abstract][Full Text] [Related]
10. [Adverse reaction of hepatic arterial infusion chemotherapy for hepatocellular carcinoma].
Tanaka M; Ando E; Itano S; Sata M
Nihon Rinsho; 2001 Oct; 59 Suppl 6():640-4. PubMed ID: 11762027
[No Abstract] [Full Text] [Related]
11. Oxaliplatin and 5-fluorouracil hepatic infusion with lipiodolized chemoembolization in large hepatocellular carcinoma.
Li JH; Xie XY; Zhang L; Le F; Ge NL; Li LX; Gan YH; Chen Y; Zhang JB; Xue TC; Chen RX; Xia JL; Zhang BH; Ye SL; Wang YH; Ren ZG
World J Gastroenterol; 2015 Apr; 21(13):3970-7. PubMed ID: 25852283
[TBL] [Abstract][Full Text] [Related]
12. [Hepatic arterial infusion chemotherapy combined with interferon-alpha for hepatocellular carcinoma].
Nagano H; Eguchi H; Sakon M; Monden M
Nihon Rinsho; 2001 Oct; 59 Suppl 6():748-52. PubMed ID: 11762050
[No Abstract] [Full Text] [Related]
13. A new chemotherapeutic regimen for advanced unresectable hepatocellular carcinoma.
Seki S; Yamada T; Kawakita N; Masuichi H; Kitada T; Sakaguchi H
Hepatogastroenterology; 2003; 50(53):1598-602. PubMed ID: 14571794
[TBL] [Abstract][Full Text] [Related]
14. Postoperative prophylactic lipiodolization reduces the intrahepatic recurrence of hepatocellular carcinoma.
Takenaka K; Yoshida K; Nishizaki T; Korenaga D; Hiroshige K; Ikeda T; Sugimachi K
Am J Surg; 1995 Apr; 169(4):400-4; discussion 405. PubMed ID: 7694977
[TBL] [Abstract][Full Text] [Related]
15. [Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma providing a good QOL].
Yamashita S; Niinobu T; Nakagawa S; Amano M; Nishikawa Y; Hayashida H; Higaki N; Fujita M; Sakon M
Gan To Kagaku Ryoho; 2006 Nov; 33(12):1928-30. PubMed ID: 17212149
[TBL] [Abstract][Full Text] [Related]
16. Systemic therapy for hepatocellular carcinoma.
Leung TW; Johnson PJ
Semin Oncol; 2001 Oct; 28(5):514-20. PubMed ID: 11685744
[TBL] [Abstract][Full Text] [Related]
17. [Standard chemotherapy for colonic neoplasms].
Hyodo I
Nihon Naika Gakkai Zasshi; 2007 Feb; 96(2):283-8. PubMed ID: 17370594
[No Abstract] [Full Text] [Related]
18. [The present status of chemotherapy for hepatocellular carcinoma].
Itsubo M
Gan To Kagaku Ryoho; 1993 May; 20(7):889-95. PubMed ID: 8387760
[TBL] [Abstract][Full Text] [Related]
19. [Hepatic arterial infusion chemotherapy using totally implantable port system].
Takayasu Y; Yamamoto S; Ikeda J
Gan To Kagaku Ryoho; 2000 Sep; 27(10):1516-20. PubMed ID: 11015995
[TBL] [Abstract][Full Text] [Related]
20. [A case of spindle cell type hepatocellular carcinoma responding to hepatic intra-arterial infusion chemotherapy].
Maruyama T; Nozue M; Aoyagi H; Sakamoto T; Fukue M; Matsui S; Kodaira Y; Monma E; Takada Y; Shidara S; Ikezawa K; Yoshida T; Shimakura S
Gan To Kagaku Ryoho; 2002 Jan; 29(1):137-41. PubMed ID: 11816471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
